Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but ...

A research team has uncovered a previously unknown type of immune signaling molecule—a novel compound combining histidine and ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...

As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like a year, thanks to excellent clinical or regulatory progress. Read on to ...

The Dubs might not have the same strength in their numbers that they once boasted. Curry and Draymond Green’s legs might not ...

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

The company, co-founded by Jennifer Doudna, the scientist who won a Nobel Prize for her CRISPR discoveries, uses CRISPR to edit T cells sourced from healthy donors. Those edits enable these one ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

The specialist in CRISPR-based gene editing – co-founded by Nobel Prize winner Jennifer Doudna – said it is focusing on NTLA-2002 for hereditary angioedema (HAE) and nexiguran ziclumeran (nex ...

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...